These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
526 related items for PubMed ID: 18094224
1. Effects of ibuprofen on the magnitude and duration of aspirin's inhibition of platelet aggregation: clinical consequences in stroke prophylaxis. Gengo FM, Rubin L, Robson M, Rainka M, Gengo MF, Mager DE, Bates V. J Clin Pharmacol; 2008 Jan; 48(1):117-22. PubMed ID: 18094224 [Abstract] [Full Text] [Related]
3. Pharmacodynamic interaction of naproxen with low-dose aspirin in healthy subjects. Capone ML, Sciulli MG, Tacconelli S, Grana M, Ricciotti E, Renda G, Di Gregorio P, Merciaro G, Patrignani P. J Am Coll Cardiol; 2005 Apr 19; 45(8):1295-301. PubMed ID: 15837265 [Abstract] [Full Text] [Related]
4. Double-blind, randomized, parallel, placebo-controlled study of ibuprofen effects on thromboxane B2 concentrations in aspirin-treated healthy adult volunteers. Cryer B, Berlin RG, Cooper SA, Hsu C, Wason S. Clin Ther; 2005 Feb 19; 27(2):185-91. PubMed ID: 15811481 [Abstract] [Full Text] [Related]
5. The antiplatelet effect of six non-steroidal anti-inflammatory drugs and their pharmacodynamic interaction with aspirin in healthy volunteers. Gladding PA, Webster MW, Farrell HB, Zeng IS, Park R, Ruijne N. Am J Cardiol; 2008 Apr 01; 101(7):1060-3. PubMed ID: 18359332 [Abstract] [Full Text] [Related]
6. Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin. Schiff M, Hochberg MC, Oldenhof J, Brune K. Curr Med Res Opin; 2009 Oct 01; 25(10):2471-7. PubMed ID: 19678751 [Abstract] [Full Text] [Related]
7. Magnitude and time course of platelet inhibition with Aggrenox and Aspirin in patients after ischemic stroke: the AGgrenox versus Aspirin Therapy Evaluation (AGATE) trial. Serebruany VL, Malinin AI, Sane DC, Jilma B, Takserman A, Atar D, Hennekens CH. Eur J Pharmacol; 2004 Sep 24; 499(3):315-24. PubMed ID: 15381054 [Abstract] [Full Text] [Related]
8. A randomized, controlled study on the influence of acetaminophen, diclofenac, or naproxen on aspirin-induced inhibition of platelet aggregation. Galliard-Grigioni KS, Reinhart WH. Eur J Pharmacol; 2009 May 01; 609(1-3):96-9. PubMed ID: 19272375 [Abstract] [Full Text] [Related]
9. Celecoxib, ibuprofen, and the antiplatelet effect of aspirin in patients with osteoarthritis and ischemic heart disease. Renda G, Tacconelli S, Capone ML, Sacchetta D, Santarelli F, Sciulli MG, Zimarino M, Grana M, D'Amelio E, Zurro M, Price TS, Patrono C, De Caterina R, Patrignani P. Clin Pharmacol Ther; 2006 Sep 01; 80(3):264-74. PubMed ID: 16952493 [Abstract] [Full Text] [Related]
10. Platelet aggregation and recruitment with aspirin-clopidogrel therapy. Helgason CM, Grossi E, Pandey D, Valika A, Cursio J, Brace LD. Cerebrovasc Dis; 2008 Sep 01; 25(5):392-400. PubMed ID: 18349532 [Abstract] [Full Text] [Related]
11. Population pharmacodynamic modelling of aspirin- and Ibuprofen-induced inhibition of platelet aggregation in healthy subjects. Hong Y, Gengo FM, Rainka MM, Bates VE, Mager DE. Clin Pharmacokinet; 2008 Sep 01; 47(2):129-37. PubMed ID: 18193919 [Abstract] [Full Text] [Related]
12. Low-dose naproxen interferes with the antiplatelet effects of aspirin in healthy subjects: recommendations to minimize the functional consequences. Anzellotti P, Capone ML, Jeyam A, Tacconelli S, Bruno A, Tontodonati P, Di Francesco L, Grossi L, Renda G, Merciaro G, Di Gregorio P, Price TS, Garcia Rodriguez LA, Patrignani P. Arthritis Rheum; 2011 Mar 01; 63(3):850-9. PubMed ID: 21360514 [Abstract] [Full Text] [Related]
13. Influence of non-steroidal anti-inflammatory drugs on antiplatelet effect of aspirin. Yokoyama H, Ito N, Soeda S, Ozaki M, Suzuki Y, Watanabe M, Kashiwakura E, Kawada T, Ikeda N, Tokuoka K, Kitagawa Y, Yamada Y. J Clin Pharm Ther; 2013 Feb 01; 38(1):12-5. PubMed ID: 22882748 [Abstract] [Full Text] [Related]
14. Effect of picotamide and aspirin, combined or alone, on platelet aggregation in patients with cerebral infarction. D'Andrea G, Perini F, Hasselmark L, Alecci M, Cananzi AR. Funct Neurol; 1995 Feb 01; 10(2):91-8. PubMed ID: 7557557 [Abstract] [Full Text] [Related]
15. Prevalence of platelet nonresponsiveness to aspirin in patients treated for secondary stroke prophylaxis and in patients with recurrent ischemic events. Gengo FM, Rainka M, Robson M, Gengo MF, Forrest A, Hourihane M, Bates V. J Clin Pharmacol; 2008 Mar 01; 48(3):335-43. PubMed ID: 18223144 [Abstract] [Full Text] [Related]
16. A Thrombelastograph whole blood assay for clinical monitoring of NSAID-insensitive transcellular platelet activation by arachidonic acid. Carroll RC, Craft RM, Chavez JJ, Snider CC, Bresee SJ, Cohen E. J Lab Clin Med; 2005 Jul 01; 146(1):30-5. PubMed ID: 16025089 [Abstract] [Full Text] [Related]
17. Ibuprofen interferes with aspirin's benefits. Health News; 2003 Apr 01; 9(4):6. PubMed ID: 12710393 [No Abstract] [Full Text] [Related]
18. Concomitant use of ibuprofen and aspirin. Food and Drug Administration U.S. Department of Health and Human Services. J Pain Palliat Care Pharmacother; 2007 Apr 01; 21(2):73-4. PubMed ID: 17844731 [Abstract] [Full Text] [Related]
19. Rapid platelet inhibition after a single capsule of Aggrenox: challenging a conventional full-dose aspirin antiplatelet advantage? Serebruany VL, Malinin AI, Sane DC. Am J Hematol; 2003 Apr 01; 72(4):280-1. PubMed ID: 12666142 [Abstract] [Full Text] [Related]
20. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. Catella-Lawson F, Reilly MP, Kapoor SC, Cucchiara AJ, DeMarco S, Tournier B, Vyas SN, FitzGerald GA. N Engl J Med; 2001 Dec 20; 345(25):1809-17. PubMed ID: 11752357 [Abstract] [Full Text] [Related] Page: [Next] [New Search]